144 related articles for article (PubMed ID: 36521917)
1. Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study.
Alduraibi FK; Saleem M; Ricart K; Patel RP; Szalai AJ; Singh JA
J Rheumatol; 2023 Jun; 50(6):817-826. PubMed ID: 36521917
[TBL] [Abstract][Full Text] [Related]
2. Revisiting comorbidities in gout: a cluster analysis.
Richette P; Clerson P; Périssin L; Flipo RM; Bardin T
Ann Rheum Dis; 2015 Jan; 74(1):142-7. PubMed ID: 24107981
[TBL] [Abstract][Full Text] [Related]
3. The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study.
Liang J; Jiang Y; Huang Y; Song W; Li X; Huang Y; Ou J; Wei Q; Gu J
Lipids Health Dis; 2020 Mar; 19(1):31. PubMed ID: 32127000
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review.
Bevis M; Blagojevic-Bucknall M; Mallen C; Hider S; Roddy E
Rheumatology (Oxford); 2018 Aug; 57(8):1358-1363. PubMed ID: 29672754
[TBL] [Abstract][Full Text] [Related]
5. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
[TBL] [Abstract][Full Text] [Related]
6. The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors-30 years follow-up of the Malmö Preventive Project.
Fatima T; Nilsson PM; Turesson C; Dehlin M; Dalbeth N; Jacobsson LTH; Kapetanovic MC
Arthritis Res Ther; 2020 Oct; 22(1):244. PubMed ID: 33066806
[TBL] [Abstract][Full Text] [Related]
7. Acute gout attacks during the perioperative period and risk factors of recurrence after orthopedic surgery among untreated gout patients.
Wang H; Yan C; Wu Q; Zeng H; Zhang Z; Wang W; Sun X
J Orthop Surg Res; 2023 Jan; 18(1):61. PubMed ID: 36683056
[TBL] [Abstract][Full Text] [Related]
8. Levels of Cytokines and MicroRNAs in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench-to-Bedside Approach.
Estevez-Garcia IO; Gallegos-Nava S; Vera-Pérez E; Silveira LH; Ventura-Ríos L; Vancini G; Hernández-Díaz C; Sánchez-Muñoz F; Ballinas-Verdugo MA; Gutierrez M; Pineda C; Rodriguez-Henriquez P; Castillo-Martínez D; Amezcua-Guerra LM
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1814-1821. PubMed ID: 29457379
[TBL] [Abstract][Full Text] [Related]
9. [Hyperuricemia and Gout].
Delbarba E; Terlizzi V; Dallera N; Izzi C; Scolari F
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960024
[TBL] [Abstract][Full Text] [Related]
10. Uric acid is independently associated with interleukin-1β levels in tear fluid of hyperuricemia and gout patients.
Wu M; Hu X; Lu T; Liu C; Lu H
Immun Inflamm Dis; 2023 Mar; 11(3):e805. PubMed ID: 36988248
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of urinary calculi in men with gout.
Cao Y; Han X; Wang X; Zhang Y; Xiao H; Zeng X
Clin Rheumatol; 2022 Oct; 41(10):3143-3150. PubMed ID: 35739406
[TBL] [Abstract][Full Text] [Related]
12. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia].
Glasnović M
Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities in patients with gout.
Ichikawa N; Taniguchi A; Urano W; Nakajima A; Yamanaka H
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1045-50. PubMed ID: 22132955
[TBL] [Abstract][Full Text] [Related]
14. Burden and management of gout in a multi-ethnic Asian cohort.
Chua CKT; Cheung PP; Santosa A; Lim AYN; Teng GG
Rheumatol Int; 2020 Jul; 40(7):1029-1035. PubMed ID: 31758246
[TBL] [Abstract][Full Text] [Related]
15. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
[TBL] [Abstract][Full Text] [Related]
16. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.
Lu CC; Wu SK; Chen HY; Chung WS; Lee MC; Yeh CJ
J Rheumatol; 2014 Sep; 41(9):1878-83. PubMed ID: 25086077
[TBL] [Abstract][Full Text] [Related]
18. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
Bakris GL; Doghramji PP; Keenan RT; Silber SH
Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
[TBL] [Abstract][Full Text] [Related]
19. GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003).
Lioté F; Lancrenon S; Lanz S; Guggenbuhl P; Lambert C; Saraux A; Chiarelli P; Delva C; Aubert JP; Ea HK
Joint Bone Spine; 2012 Oct; 79(5):464-70. PubMed ID: 22281230
[TBL] [Abstract][Full Text] [Related]
20. Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.
Sharon Y; Schlesinger N
Curr Rheumatol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
